Strides Pharma Science Share Price Live
STAR
Small Cap | Pharmaceuticals
Live Strides Pharma Science Share Price Chart
O H L VOL
Days Range
Data is not available currently. Please check back later.
Data is not available currently. Please check back later.
About Strides Pharma Science
History
Strides Pharma Science Ltd was incorporated, originally under the name 'Strides Arcolab Ltd', on June 28th, 1990. In 2002-03, the company signed an MoU with Ribbon SRL Italy to set up a joint venture to manufacture and market Cephalosporin formulations for regulated markets. The company transferred its Contract Research and Manufacturing Division (CRAM) to the wholly owned subsidiary, Strides Research & Specialty Chemicals Ltd, effective from April 1, 2002. In 2005, the company established its new technology centre named STAR-Strides Technology and Research. They also expanded their Anti TB Facility at KRS Gardens, Bengaluru. In 2008, the company completed a series of divestments and acquisitions and rearranged its business into 3 specific business segments, namely Manufacturing and R&D, International Front-ended Business-Generics and Brands and Nutraceuticals Business. In April 2009, they announced a major reorganisation of their business whereby they split their operations into 3 separate entities, namely Specialty Pharmaceuticals, Pharmaceuticals & R&D. In December 2012, the company with its subsidiary Agila Specialties Private Ltd collaborated with Eli Lilly to expand the delivery of its cancer medicines in emerging markets. As a part of this arrangement, Lilly in-licensed a portfolio of high-quality, branded generic injectable and oral cancer medicines from Agila Specialties, the specialities division of Strides. In FY 2018, the company exited from the India Brand Business. In 2018-19, the R&D operations of the company remained on track with 21 ANDA filings as against the 20-25 ANDA filings planned for the year. The company also received 15 product approvals in FY 2019. This included the PARA IV approvals for Cinacalcet and Milnacipran Hydrochloride.Business Segments
As per accounting terms, the company has two business segments reported, i.e. pharmaceutical and bio-pharmaceutical businesses. In terms of the diseases cured, the company’s institutional business is divided into the following categories:- AIDS - The focus of Strides is on the production and supply of newer anti-retroviral drugs that are difficult to manufacture, including pediatric dispersible formulations, new fixed-dose molecules which Strides accesses through license agreements with Gilead, Vive Healthcare, MPP, among others.
- TB or Tuberculosis - Strides has its own state-of-the-art anti-TB drug facility formulating the second-line TB drug.
- Malaria - Strides has begun the supply of WHO Pre-Qualified Artemether and Lumefantrine (AL) Tablets, and also AL Dispersible tablets for pediatric use. It has ERP approval for AL 80/480 and Artesunate Suppositories caps.
- Hepatitis - Strides has launched “Sofosbuvir and it’s combination drugs” in Africa, South East Asia, CIS and Latam countries for Hepatitis C treatment. This represents a paradigm shift in the existing Hepatitis C cure.
- Altima Innovations Inc. - It is a wholly owned subsidiary engaged in trading in pharmaceutical products in the USA.
- Generic Partners UK Ltd. - It is a wholly owned subsidiary that supplies and distributes generic pharmaceutical products in the UK.
- Pharmapar Inc. - It is a wholly owned subsidiary that trades in pharmaceutical products in Canada.
- Strides Pharma Global (UK) Ltd. - It is an Investment Holding company in the UK that is 100% owned by Strides Pharma Science.
Key Personnel
Mr Arun Kumar, Executive Chairperson and Managing Director Mr Kumar is the Company’s Founder and also the Promoter Director. He is a first-generation entrepreneur with an impressive track record. He founded the company in 1990 and has since led it in establishing a global reputation along with a differentiated business model.Corporate Actions
The company has not performed any major corporate actions in the recent past. Mergers and Acquisitions- In January 2020, the Board of Directors of the company allowed the merger of its wholly-owned subsidiary, Vivimed Life Sciences Pvt Ltd (Vivimed) into the Company.
- In September 2019, Strides Pharma Global Pte. Limited (SPG), a step-down subsidiary in Singapore, acquired a 70% equity stake in Fairmed Healthcare AG (Fairmed), a Switzerland-based generic pharma company.
- In FY 2016, the company acquired the erstwhile Ranbaxy's Solus' and Solus Care' divisions which were operating in the Central Nervous System (CNS) segment in India from Sun Pharmaceuticals Limited.
Parent Organisation
Indian Private
Managing Director
Arun Kumar
Founded
1990
NSE Symbol
STAR
Community Discussion
A
AngelOne
10th July 2024
0 Likes
0 Replies
A
AngelOne
10th July 2024
Strides Pharma Science Ltd-latest-market-updates-3896
0 Likes
0 Replies
Strides Pharma Science Ltd FAQs
What is the share price of Strides Pharma Science Ltd (STAR) shares?
Strides Pharma Science Ltd (STAR) share price as of July 26, 2024, on NSE is Rs 1023 (NSE) and Rs 1023 (BSE) on BSE.
Can I buy Strides Pharma Science Ltd (STAR) from Angel One?
Yes, You can buy Strides Pharma Science Ltd (STAR) shares by opening a Demat account with Angel One.
How do I buy Strides Pharma Science Ltd (STAR) from Angel One?
Strides Pharma Science Ltd (STAR) share can be bought through the following modes:
1. Direct investment: You can buy Strides Pharma Science Ltd (STAR) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Strides Pharma Science Ltd (STAR) shares.
1. Direct investment: You can buy Strides Pharma Science Ltd (STAR) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Strides Pharma Science Ltd (STAR) shares.
What is the main business of Strides Pharma Science (STAR)?
Strides Pharma Science Ltd is involved in the development and manufacturing of pharmaceutical products.
Who are the promoters of Strides Pharma Science (STAR)?
Pronomz Ventures Llp, Arun Kumar Pillai, and Karuna Business Solutions Llp are the major promoters of Strides Pharma Science.
What are the Subsidiaries that comes under Strides Pharma Science (STAR)?
Altima Innvovations Inc., Apollo Life Sciences Holdings Proprietary Limited, and Arco Lab Private Limited are a few subsidiaries that come under Strides Pharma Science.
Open Free Demat Account!
Enjoy Zero Brokerage on Equity Delivery
Join our 2 Cr+ happy customers
Related Blogs
View All
4.4 Cr+DOWNLOADS
Enjoy Zero Brokerage on Equity Delivery
Get the link to download the App
